Business
Telix (ASX:TLX) share price lower despite key FDA update
Image source: Getty Images
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is edging lower on Thursday morning despite the release of a positive announcement.
At the time of writing, the biopharmaceuticals company’s shares are down slightly to $5.61.
What did Telix…
Continue Reading
-
General18 hours agoQueensland government expands youth justice laws, David Crisafulli tells UN critics ‘you don’t control me’
-
General21 hours agoRestaurants on the brink as business failures plateau
-
General10 hours agoThree maps that show the scale of the NSW flood disaster
-
General21 hours agoRegional house price growth outstrips capital cities